Rod-like mesoporous silica nanoparticles facilitate oral drug delivery via enhanced permeation and retention effect in mucus
The physiochemical characteristics of nanoparticles affect their in vitro and in vivo performance significantly, such as diameter, surface chemistry, and shape. This paper disclosed the effect of enhanced permeation and retention (EPR) in mucus caused by nanoparticle shape on improving oral absorpti...
Gespeichert in:
Veröffentlicht in: | Nano research 2022-10, Vol.15 (10), p.9243-9252 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The physiochemical characteristics of nanoparticles affect their
in vitro
and
in vivo
performance significantly, such as diameter, surface chemistry, and shape. This paper disclosed the effect of enhanced permeation and retention (EPR) in mucus caused by nanoparticle shape on improving oral absorption. The spherical and rod-like mesoporous silica nanoparticles (MSNs) were used to evaluate shape effect of EPR in mucus. Fenofibrate was loaded in MSNs as model drug. The
in vitro
release of fenofibrate from MSNs was dependent on nanoparticle shapes, but faster than that of raw drug. The drug release slowed down with the increase of aspect ratio due to longer channels in rod-like MSNs with higher aspect ratio. However,
in vivo
study showed that the oral bioavailability of fenofibrate was the highest after loading in rod-like MSNs with aspect ratio of 5. The
in vitro
study of mechanisms revealed that superior mucus diffusion ability of rod-like MSNs with aspect ratio of 5 was conductive to higher bioavailability. Meanwhile, more rod-like MSNs with higher aspect ratio were able to diffuse into mucus and reside there compared to spherical and short counterparts, which demonstrated higher aspect ratio was beneficial to EPR effect of nanoparticles in mucus. This study provides significant implication in rational oral drug carrier design. |
---|---|
ISSN: | 1998-0124 1998-0000 |
DOI: | 10.1007/s12274-022-4601-2 |